Author: Healio ophthalmology

Physicians debate ACGME’s Milestones initiative

The Accreditation Council for Graduate Medical Education’s Milestones initiative and its role in internal medicine are a source of debate for physicians. According to recently published findings, many physicians agree the Milestones program is challenging to implement; therefore, making it an inaccurate and invaluable method of educating and assessing residents’ performance. However, Accreditation Council for Graduate Medical Education (ACGME) asserts it is taking the necessary measures to mend the issue and enhance the Milestones program.

Top five stories from ESCRS

Clinical research, new technologies and evolving treatments were among the most discussed topics at the 2016 European Society of Cataract and Refractive Surgeons meeting in Copenhagen. New cataract surgery techniques and promising treatments for myopia…

Publication Exclusive: Intrastromal corneal ring segment helps correct high astigmatism after DALK

Corneal transplantation has progressed significantly from full-thickness penetrating keratoplasty to selective corneal transplantation in which only the diseased portions of corneal tissue are replaced surgically with similar healthy donor tissue. This has revolutionized corneal transplantation because the healthy parts of the patient’s cornea are retained. When the endothelium is untouched surgically, this eliminates the possibility of endothelial graft rejection. The diseased portion of the cornea needs to be localized to the anterior regions of the patient’s cornea, such as in keratoconus, while the endothelium remains healthy.When the corneal stroma is (Read more...)

VIDEO: Astigmatism management an issue in all types of ocular surgery

COPENHAGEN – Béatrice Cochener, MD, PhD, president elect of the European Society of Cataract and Refractive Surgeons, talks about management of astigmatism, a key topic in all branches of eye surgery and particularly in cataract surgery. The latest advances in techniques and technology offer unique opportunities to deal effectively with this challenging component of the refractive error. 

Heidelberg receives FDA clearance to market Spectralis OCT glaucoma module

Heidelberg Engineering received 510(k) clearance from the FDA to market the Spectralis OCT Glaucoma Module Premium Edition, which creates an anatomic map unique to each patient’s eye. The module provides clinicians with objective and automatic measurement parameters for increased diagnostic accuracy, according to a company press release. It utilizes a new technology called Anatomic Positioning System, which uses the center of the fovea and the center of Bruch’s membrane opening to create an anatomic map of the eye. Each scan thereafter is automatically oriented according to each patient’s unique anatomic (Read more...)

Survey shows extensive support for nationwide precision medicine study

A majority of adults expressed support of and willingness to participate in the Precision Medicine Initiative’s national research effort, according to recent survey data published in PLOS ONE.“Precision medicine is an emerging approach to disease prevention, diagnosis and treatment that takes into account differences between individuals. While not new, to date it has only been applied to certain conditions,” David J. Kaufman, PhD, of NIH’s National Human Genome Research Institute, and colleagues wrote. “The Precision Medicine Initiative (PMI) plans to build a comprehensive scientific knowledge base to implement precision medicine (Read more...)

GenSight Biologics expands trial of Leber’s hereditary optic neuropathy treatment to include teenage patients

GenSight Biologics announced that regulatory agencies and ethics committees in the United States, France and the United Kingdom have approved a protocol amendment to include teenage patients aged 15 to 18 years in its two ongoing phase 3 clinical trials of GS010. According to a GenSight press release, the phase 3 RESCUE and REVERSE clinical trials are testing the use of GS010 in the treatment of Leber’s hereditary optic neuropathy.

Most foldable IOL explantations still caused by dislocation, decentration

COPENHAGEN — Dislocation and decentration remained the most common reason for IOL explantation among all lens designs studied, while glare and aberrations were the second most common, according to an annual survey.Presented by Nick Mamalis, MD, at the European Society of Cataract and Refractive Surgeons meeting, the survey details patient complaints, symptoms and reasons for explantation or intervention among five different types of foldable IOL designs: one-piece with plate, one-piece with haptics, three-piece, multifocal and accommodating.

VIDEO: Isolated Bowman’s layer transplantation used to treat advanced keratoconus

COPENHAGEN – At the Netherlands Institute for Innovative Ocular Surgery DMEK meeting preceding the European Society of Cataract and Refractive Surgeons meeting here, Gerrit Melles, MD, summarizes the latest advances in endothelial transplantation and talks about the early results of isolated Bowman’s layer transplantation in patients with advanced keratoconus.

EyeGate receives grant to continue development of ocular bandage film

Jade Therapeutics, a subsidiary of EyeGate Pharmaceuticals, received $448,185 in funding from the U.S. Army Medical Research and Materiel Command for a second year, EyeGate announced. The funding will be used to continue developing a proprietary thiolated hyaluronic acid (CMHA-S) product, which is under study for use as an ocular bandage film, and brings the total funding Jade has received from the U.S. Army’s Small Business Innovation Research program to $1.25 million, according to a press release.